Study guide
13.3 Analgesics, Anxiolysis & Sedation
NDEB Assessment of Fundamental Knowledge AFK
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the AFK & NDEB Equivalency Process 1.2 Format, Scoring, Attempts & Exam-Day Rules 1.3 Official Blueprint Weights & Study Strategy
2 Chapter 1: Head & Neck Anatomy
1.1 Osteology, Fascial Spaces & Odontogenic Spread 1.2 Cranial Nerves Relevant to Dentistry 1.3 Vascular Supply, Lymphatics, TMJ & Mastication
3 Chapter 2: Human Physiology for Dentistry
2.1 Cardiovascular & Respiratory Physiology 2.2 Renal, Endocrine & Acid-Base Physiology 2.3 Neuromuscular Physiology & Salivary Function
4 Chapter 3: Biochemistry, Nutrition & Biomaterials
3.1 Metabolism, Enzymes & Oral Biochemistry 3.2 Vitamins, Minerals & Nutritional Deficiencies 3.3 Biomaterials Science: Properties & Biocompatibility
5 Chapter 4: Oral Histology, Embryology & Growth
4.1 Tooth Development & Oral Embryology 4.2 Enamel, Dentin, Cementum, Pulp & Periodontium Histology 4.3 Craniofacial Growth & Development
6 Chapter 5: Microbiology, Immunology & Cariology
5.1 Oral Microbiome, Pathogens & Biofilms 5.2 Immunology & Hypersensitivity in the Oral Cavity 5.3 Cariology: Etiology, Progression & Prevention Science
7 Chapter 6: Dental Anatomy & Occlusion
6.1 Permanent & Primary Tooth Morphology & Roots 6.2 Eruption Sequences & FDI Numbering 6.3 Occlusion Principles & Angle Classification
8 Chapter 7: Restorative Principles & Direct Materials
7.1 Caries Diagnosis & Operative Principles 7.2 Amalgam, Composite Resin & Glass Ionomer 7.3 Adhesion, Bonding & Pulp Protection
9 Chapter 8: Indirect Restorations & Prosthodontics
8.1 Crowns, Bridges, Onlays & Preparation Design 8.2 Complete Dentures & Removable Partial Dentures 8.3 Occlusion Concepts in Prosthodontics
10 Chapter 9: Implants & Advanced Restorative
9.1 Implant Biology & Osseointegration 9.2 Implant Planning, Prosthetics & Complications 9.3 Clinical Dental Materials Selection & Failures
11 Chapter 10: Oral Medicine — Mucosal Disease
10.1 White, Red & Ulcerative Mucosal Lesions 10.2 Oral Cancer & Premalignant Conditions 10.3 Vesiculobullous & Immune-Mediated Mucosal Disease
12 Chapter 11: Oral Pathology — Hard Tissues
11.1 Cysts of the Jaws 11.2 Odontogenic Tumors 11.3 Bone Pathology & Fibro-Osseous Lesions
13 Chapter 12: Salivary Disease, Systemic Manifestations & Oral Radiology
12.1 Salivary Gland Disease 12.2 Systemic Disease Oral Manifestations 12.3 Radiation Physics & Radiographic Technique 12.4 Radiographic Anatomy, Lesions & Interpretation
14 Chapter 13: Local Anesthesia & Analgesia
13.1 Local Anesthetics & Vasoconstrictors 13.2 Injection Techniques, Failures & Complications 13.3 Analgesics, Anxiolysis & Sedation
15 Chapter 14: Systemic Pharmacology & Medical Emergencies
14.1 Antibiotics & Antimicrobials in Dentistry 14.2 Drug Interactions & the Medically Compromised Patient 14.3 Recognition of Medical Emergencies in the Dental Office 14.4 Emergency Drugs & Management Protocols
16 Chapter 15: Periodontics Foundations
15.1 Periodontal Anatomy & Pathogenesis 15.2 2017 AAP Classification of Periodontal Diseases 15.3 Periodontal Examination & Diagnosis
17 Chapter 16: Periodontal Therapy & Systemic Links
16.1 Nonsurgical Periodontal Therapy 16.2 Surgical Periodontics Basics 16.3 Periodontal–Systemic Relationships
18 Chapter 17: Endodontics
17.1 Pulp Biology & Endodontic Diagnosis 17.2 Canal Morphology & Access Preparation 17.3 Instrumentation, Irrigation & Obturation 17.4 Endodontic Emergencies, Trauma & Retreatment
19 Chapter 18: Oral Surgery, Trauma & Orofacial Pain
18.1 Exodontia Principles & Complications 18.2 Impacted Teeth & Minor Oral Surgery 18.3 Maxillofacial Trauma 18.4 Orofacial Pain, TMD & Dental Emergencies
20 Chapter 19: Orthodontics
19.1 Growth, Development & Orthodontic Diagnosis 19.2 Malocclusion Classification & Treatment Planning 19.3 Appliances, Interceptive & Comprehensive Orthodontics
21 Chapter 20: Pediatric Dentistry
20.1 Behavior Management & Primary Dentition Care 20.2 Pediatric Pulp Therapy 20.3 Pediatric Trauma & Space Management
22 Chapter 21: Geriatric & Special Needs Dentistry
21.1 Geriatric Dentistry Considerations 21.2 Special Needs Patients in Dental Practice
23 Chapter 22: Prevention & Evidence-Based Dentistry
22.1 Fluoride, Sealants & Prevention Strategies 22.2 Epidemiology, Caries Indices & Public Health 22.3 Evidence-Based Dentistry & Biostatistics
24 Chapter 23: Infection Control, Ethics & Jurisprudence
23.1 Infection Control & Sterilization 23.2 Ethics & Professionalism for Canadian Practice 23.3 Jurisprudence, Consent & Clinical Records
25 Chapter 24: Integrated Review & Exam Strategy
24.1 High-Yield Differentials Across Domains 24.2 Case Vignette Reasoning Patterns 24.3 Exam-Day Strategy & Pathway Next Steps (ACJ/NDECC)
13.3 Analgesics, Anxiolysis & Sedation
Key Takeaways Explain This Topic AI
NSAIDs are first-line for inflammatory dental pain when not contraindicated (GI ulcer, significant renal disease, late pregnancy, NSAID-exacerbated respiratory disease); acetaminophen is the primary alternative and combination partner.
Opioids are second-line short-course options for severe acute pain; avoid routine combinations with benzodiazepines/alcohol and respect codeine CYP2D6 pediatric safety limits.
Nitrous oxide–oxygen offers titratable anxiolysis with rapid recovery; end with 100% oxygen to prevent diffusion hypoxia and respect pregnancy/respiratory contraindications.
Oral conscious sedation requires training, monitoring, escort home, and flumazenil readiness while remaining in minimal-to-moderate sedation on the continuum toward general anesthesia.
ASA physical status (I–VI) guides venue and sedation depth: ASA I–II fit most office care; ASA III needs caution/consult; ASA IV+ is generally inappropriate for routine outpatient oral sedation.
Last updated: July 2026
13.3 Analgesics, Anxiolysis & Sedation
Quick Answer: Dental pain is usually inflammatory — NSAIDs (ibuprofen, naproxen) are first-line when not contraindicated; acetaminophen is the main alternative/add-on; opioids are reserved for severe acute pain short-term with caution. Nitrous oxide–oxygen provides titration-friendly anxiolysis with rapid recovery. Oral conscious sedation (e.g., benzodiazepines) requires training, monitoring, and strict patient selection. Always stratify risk with ASA physical status , medical history, airway, and fasting/escort rules appropriate to sedation depth.
This section closes the LA/analgesia chapter by moving from chairside nerve blocks to post-operative pain control and anxiety/sedation pathways—high-yield for both pharmacology (~14% AFK domain family) and safe clinical judgment.
Pain Physiology Relevant to Drug Choice
Nociception from pulpitis, extraction sockets, and surgical trauma is driven by prostaglandins, bradykinin, histamine , and central sensitization. Blocking prostaglandin synthesis with NSAIDs attacks the source of much dental pain more effectively than opioids alone for many post-extraction and endodontic scenarios. Combining peripheral (NSAID) and central (acetaminophen ± limited opioid) mechanisms is the modern multimodal approach.
- Analgesic class Primary mechanism (teaching) Best dental role
- NSAIDs COX inhibition → ↓ prostaglandins First-line inflammatory dental pain
Acetaminophen Central COX/peroxidase pathways (not fully settled); antipyretic When NSAIDs contraindicated; combination therapy
Opioids μ-receptor agonists in CNS Severe acute pain, short courses, second-line
Corticosteroids Broad anti-inflammatory gene effects Selected surgical swelling protocols (not routine OTC pain)
- Long-acting LA Peripheral Na⁺ channel block Pre-emptive/prolonged post-op numbness (bupivacaine)
- NSAIDs
Common agents: ibuprofen , naproxen , diclofenac , ketorolac (potent; short-term), celecoxib (COX-2 selective).
Topic AFK points
Efficacy Ibuprofen 400–600 mg often equals or beats combination opioid-acetaminophen for many dental pains in studies—know the principle
Ceiling Analgesic ceiling exists; escalating beyond anti-inflammatory doses adds adverse effects more than analgesia
GI risk Dyspepsia, ulcer, bleeding—worse with age, prior ulcer, anticoagulants, corticosteroids, alcohol
Renal Afferent arteriolar prostaglandins protect GFR in low-flow states—caution in dehydration, CKD, ACEI/ARB + diuretic (“triple whammy”)
CV Some NSAIDs raise CV event risk with chronic use; balance against benefit for short dental courses
Platelets Non-selective NSAIDs inhibit platelet function (aspirin irreversible; others reversible)—surgical bleeding consideration
Asthma/allergy Aspirin-exacerbated respiratory disease: avoid non-selective NSAIDs
Pregnancy Avoid especially 3rd trimester (ductus arteriosus, oligohydramnios concerns)—use current obstetric guidance; acetaminophen often preferred
Interaction ↑ bleeding with warfarin/DOACs/SSRIs; attenuate antihypertensives; methotrexate toxicity risk
Ketorolac is useful short-term for moderate–severe pain but limited duration (days) because of GI/renal toxicity—not a casual multi-week dental script.
Acetaminophen (Paracetamol)
- Feature Detail
- Role Analgesic/antipyretic without significant anti-inflammatory effect at usual doses
- When first choice NSAID contraindication (ulcer, CKD, late pregnancy, NSAID allergy, anticoagulation concerns)
- Combination With ibuprofen (staggered or combined protocols) improves analgesia without opioid
Toxicity Hepatotoxicity in overdose; chronic heavy alcohol use, malnutrition, induced CYP enzymes increase risk
Max daily dose Teaching often 3–4 g/day adult maximum depending on jurisdiction/label— count combination products (many opioid combos already contain acetaminophen)
Pediatric Weight-based dosing critical; liquid concentration errors are a classic toxicity path
AFK trap: patient already taking “extra-strength” acetaminophen OTC + prescribed opioid-acetaminophen → silent hepatic overdose .
Opioids in Dentistry
Agents historically used: codeine, oxycodone, hydrocodone (availability varies by country), tramadol (weak μ agonist + monoamine effects).
Principle Application
Stewardship Prefer NSAID ± acetaminophen first; opioids only when expected pain severe or multimodal insufficient
- Duration Shortest course (often ≤3 days) for acute post-op pain
- Adverse effects Nausea, constipation, sedation, respiratory depression, dependence, diversion
Codeine Prodrug needing CYP2D6 to morphine—ultra-rapid metabolizers (especially children) risk overdose; poor metabolizers get little analgesia; many pediatric restrictions worldwide
Tramadol Seizure risk, serotonin syndrome with SSRIs/SNRIs/MAOIs; still misuse potential
Interactions Additive CNS/respiratory depression with benzodiazepines, alcohol, other sedatives— black-box level concern for opioid + benzo combinations
Special populations Elderly: start low; avoid in active substance use disorder without specialist plan; pregnancy/breastfeeding—prefer non-opioids when possible
Canadian practice context (concept): emphasize non-opioid first-line dental analgesia consistent with national stewardship messaging; know your provincial prescribing rules beyond AFK science.
- Multimodal Post-Operative Pain Ladder (Dental)
- Pre-emptive: long-acting LA at surgery end; consider pre-op NSAID if not contraindicated
- Mild–moderate: ibuprofen (or naproxen) scheduled initially, not only PRN
- Add acetaminophen on schedule staggered with NSAID
- Severe breakthrough: short-course opioid combination or opioid alone if acetaminophen already maxed
Non-drug: cold packs early, head elevation, soft diet, oral hygiene, patient education (peak pain often 24–48–72 h post-extraction)
Nitrous Oxide–Oxygen Inhalation
N₂O is an inhalational anxiolytic/analgesic adjunct widely used in dentistry.
- Feature Detail
- Properties Low blood:gas solubility → rapid onset and recovery ; titration possible
- Delivery Fail-safe machines limit minimum O₂ (commonly ≥30% O₂); scavenging mandatory for staff safety
Effects Euphoria, reduced anxiety, mild analgesia, relative analgesia stage; patient remains conscious and responsive at proper titration
Technique 100% O₂ start/end; titrate N₂O in 10% steps typically; watch for oversedation (mouth breathing, agitation, nausea)
Diffusion hypoxia At end, N₂O leaves blood into alveoli and can dilute O₂— give 100% O₂ for several minutes before dismissing
Contraindications / cautions Nasal obstruction, COPD/severe respiratory compromise, middle ear/sinus surgery recent, bleomycin history (O₂ issues), first trimester pregnancy (avoid elective), vitamin B₁₂ deficiency/chronic exposure neuropathy (staff), inability to understand/cooperate, severe claustrophobia with mask, some psychiatric instability
Advantages Non-invasive, titratable, rapid recovery, no escort often required at pure N₂O levels (jurisdiction/office policy)
Limitations Not adequate alone for highly invasive procedures in extremely phobic patients; nausea possible; requires nasal breathing
Oral Conscious Sedation Principles
Oral sedation (commonly benzodiazepines such as triazolam, diazepam, lorazepam—agent availability varies) produces minimal to moderate sedation when used appropriately—not general anesthesia.
Domain Requirements / teaching points
Goals Anxiolysis, cooperation, amnesia possible; maintain independent airway and response to verbal command (moderate sedation definition teaching)
Training & permit Jurisdictional permits, ACLS/emergency readiness, team roles—AFK tests principles not provincial form numbers
Patient selection ASA I–II ideal; ASA III only with caution/consult; avoid complex airway, severe OSA without specialist setting, severe GERD/aspiration risk poorly controlled
Pre-op Full medical/drug history, NPO guidelines per depth, escort home mandatory for oral sedatives that impair cognition, written consent, baseline vitals
Dosing Lowest effective dose; account for age, liver disease, concurrent opioids/alcohol; no redosing casually from waiting-room “top-ups” without protocol
Monitoring BP, pulse, SpO₂, clinical responsiveness; continuous observation; supplemental O₂ as indicated
Reversal Flumazenil reverses benzodiazepines (seizure risk in chronic benzo users; resedation possible—monitor length)
Discharge Stable vitals, oriented, ambulating with escort, written post-op instructions, emergency contacts
Dangerous combinations Oral benzo + opioid + antihistamine “stacks” → respiratory depression; polypharmacy is a major morbidity pathway
Minimal vs moderate vs deep sedation vs GA (continuum):
- Level Responsiveness Airway
- Minimal (anxiolysis) Normal response to verbal Unaffected
- Moderate (conscious) Purposeful response to verbal/tactile No intervention needed
- Deep Response after repeated/painful stimulation May need airway help
- General anesthesia Unarousable Often impaired; advanced airway support
Dentists must not drift into unintended deep sedation without training, monitors, and rescue capability.
ASA Physical Status Classification
The American Society of Anesthesiologists (ASA) physical status score stratifies systemic disease burden for anesthesia/sedation risk communication.
- ASA Definition (teaching) Dental examples
- I Normal healthy patient Healthy adult, non-smoker
- II Mild systemic disease Controlled HTN, controlled diabetes, mild asthma, pregnancy, obesity mild, smoker
III Severe systemic disease, not incapacitating daily function fully Uncontrolled DM/HTN, stable CAD, COPD, morbid obesity, hepatitis with functional impact
IV Severe systemic disease that is a constant threat to life Unstable angina, advanced COPD on O₂, symptomatic heart failure, hepatorenal failure
- V Moribund, not expected to survive without operation Not typical outpatient dentistry
- VI Brain-dead organ donor N/A to routine dental
AFK use of ASA:
Match venue and sedation depth to ASA (ASA IV generally hospital/specialist anesthesia—not routine oral sedation in general practice).
Combine ASA with procedure stress , airway exam (Mallampati concept recognition), and functional capacity .
Reassess after MI, stroke, recent stents—timing rules for elective care live in medical-emergency/medically compromised chapters but ASA flags urgency of consult.
Putting It Together: Clinical Vignette Patterns
Healthy anxious ASA I, simple extraction: LA + behavioral management ± N₂O; ibuprofen ± acetaminophen post-op.
ASA II controlled HTN, molar endo: limit epinephrine cartridges, profound LA, NSAID if renal OK and not interacting with antihypertensives excessively.
Peptic ulcer history: acetaminophen ± carefully considered COX-2 or gastroprotection strategies—not unrestricted ibuprofen.
Child post-op pain: weight-based acetaminophen/ibuprofen; avoid codeine; warn about soft-tissue biting after LA.
Phobic ASA II for multiple extractions: trained provider, oral moderate sedation or N₂O, escort, monitoring; not deep sedation in under-equipped office.
ASA III unstable cardiac: defer elective care; medical consult; hospital/sedation specialist if urgent dental infection.
- Rapid review list
- NSAIDs first for inflammatory dental pain; watch GI, renal, platelet, pregnancy
- Acetaminophen: safe alternative; liver ceiling; combination-product trap
- Opioids short, second-line; avoid routine benzo + opioid stacks
- N₂O: titrate, scavenger, 100% O₂ at end (diffusion hypoxia)
- Oral sedation: selection, monitoring, flumazenil, escort, permit/training
- ASA I–II outpatient friendly; III caution; IV+ not routine office oral sedation
- Multimodal > opioid-only for most dental surgery pain
Master drug tables from 13.1, techniques from 13.2, and this section’s analgesic/sedation ladder—you now cover the AFK local anesthesia and analgesia cluster end-to-end before systemic pharmacology and medical emergencies expand the same safety themes.